DK0630259T3 - Mycobacterium vaccae til behandling af længerevarende autoimmune tilstande - Google Patents

Mycobacterium vaccae til behandling af længerevarende autoimmune tilstande

Info

Publication number
DK0630259T3
DK0630259T3 DK93905460.7T DK93905460T DK0630259T3 DK 0630259 T3 DK0630259 T3 DK 0630259T3 DK 93905460 T DK93905460 T DK 93905460T DK 0630259 T3 DK0630259 T3 DK 0630259T3
Authority
DK
Denmark
Prior art keywords
treatment
prolonged
mycobacterium vaccae
autoimmune conditions
immunologically mediated
Prior art date
Application number
DK93905460.7T
Other languages
English (en)
Inventor
John Lawson Stanford
Graham Arthur William Rook
Original Assignee
Univ London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ London filed Critical Univ London
Application granted granted Critical
Publication of DK0630259T3 publication Critical patent/DK0630259T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK93905460.7T 1992-02-21 1993-02-19 Mycobacterium vaccae til behandling af længerevarende autoimmune tilstande DK0630259T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions

Publications (1)

Publication Number Publication Date
DK0630259T3 true DK0630259T3 (da) 1997-09-15

Family

ID=10710862

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93905460.7T DK0630259T3 (da) 1992-02-21 1993-02-19 Mycobacterium vaccae til behandling af længerevarende autoimmune tilstande
DK96201912T DK0763361T3 (da) 1992-02-21 1993-02-19 Mycobacterium vaccae til behandling af langsigtede autoimmune tilstande

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK96201912T DK0763361T3 (da) 1992-02-21 1993-02-19 Mycobacterium vaccae til behandling af langsigtede autoimmune tilstande

Country Status (24)

Country Link
US (1) US5885588A (da)
EP (2) EP0763361B1 (da)
JP (1) JPH07506093A (da)
KR (1) KR100275862B1 (da)
AT (2) ATE192046T1 (da)
AU (2) AU675421B2 (da)
BG (1) BG99054A (da)
BR (1) BR9305946A (da)
CA (1) CA2130117A1 (da)
CZ (1) CZ282651B6 (da)
DE (2) DE69328503T2 (da)
DK (2) DK0630259T3 (da)
ES (2) ES2145968T3 (da)
FI (1) FI943849A0 (da)
GB (1) GB9203814D0 (da)
GR (2) GR3024113T3 (da)
HU (1) HU218347B (da)
NO (1) NO311169B1 (da)
NZ (1) NZ249518A (da)
RO (1) RO117833B1 (da)
RU (1) RU2124367C1 (da)
SK (1) SK99994A3 (da)
UA (1) UA35583C2 (da)
WO (1) WO1993016727A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
DK0951289T3 (da) * 1996-12-18 2006-03-13 Stanford Rook Ltd Anvendelse af Mycobacterium vaccae til behandling af kronisk træthedssyndrom
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
PL341697A1 (en) * 1997-12-23 2001-04-23 Genesis Res & Dev Corp Ltd Compositions derived from mycobacterium vaccae and methods of using them
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2003510335A (ja) * 1999-08-06 2003-03-18 コリクサ コーポレイション 自己免疫疾患の処置のためのワクチン
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
EP1684803B1 (en) * 2003-11-14 2010-07-07 UCL Business PLC Immune modulator comprising whole cell tsukamurella bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
DE69126668T2 (de) * 1990-11-08 1997-10-23 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
DE69309915T2 (de) 1997-07-24
RU94045825A (ru) 1997-02-20
KR100275862B1 (ko) 2000-12-15
AU7188796A (en) 1997-02-06
CZ282651B6 (cs) 1997-08-13
GB9203814D0 (en) 1992-04-08
ATE151641T1 (de) 1997-05-15
NO943082L (no) 1994-10-17
GR3033772T3 (en) 2000-10-31
DE69328503D1 (de) 2000-05-31
ES2145968T3 (es) 2000-07-16
RU2124367C1 (ru) 1999-01-10
NO943082D0 (no) 1994-08-22
DE69328503T2 (de) 2000-08-24
FI943849A0 (fi) 1994-08-22
AU706122B2 (en) 1999-06-10
CA2130117A1 (en) 1993-09-02
AU675421B2 (en) 1997-02-06
GR3024113T3 (en) 1997-10-31
SK99994A3 (en) 1995-05-10
HU9402422D0 (en) 1994-10-28
BG99054A (en) 1995-08-28
DK0763361T3 (da) 2000-08-07
UA35583C2 (uk) 2001-04-16
EP0763361B1 (en) 2000-04-26
WO1993016727A1 (en) 1993-09-02
EP0630259A1 (en) 1994-12-28
NZ249518A (en) 1997-07-27
EP0763361A2 (en) 1997-03-19
NO311169B1 (no) 2001-10-22
DE69309915D1 (de) 1997-05-22
EP0763361A3 (en) 1997-03-26
CZ202394A3 (en) 1995-02-15
ATE192046T1 (de) 2000-05-15
KR950700755A (ko) 1995-02-20
US5885588A (en) 1999-03-23
RO117833B1 (ro) 2002-08-30
HUT69941A (en) 1995-09-28
JPH07506093A (ja) 1995-07-06
ES2104131T3 (es) 1997-10-01
AU3637793A (en) 1993-09-13
EP0630259B1 (en) 1997-04-16
HU218347B (hu) 2000-08-28
BR9305946A (pt) 1997-10-21

Similar Documents

Publication Publication Date Title
DK0630259T3 (da) Mycobacterium vaccae til behandling af længerevarende autoimmune tilstande
DK0556241T3 (da) Mycobacterium vaccae til behandling af uveitis
EP0537191A4 (en) Treatment of organ transplantation rejection
CA2095627A1 (en) Stable lyophilized fatty emulsions and a process for the production thereof
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
NO920331L (no) Biologisk preparat samt bruk derav
RU93004600A (ru) Применение mycobacterium vaccae, способ лечения, продукт m vaccae, иммунотерапевтический агент
DK0413329T3 (da) 5-methyl-isoxazol-4-carboxylsyreanilider og 2-hydroxyethyliden-cyaneddikesyreanilider til behandling af øjensygdomme
ATE134705T1 (de) Rekombinantes hyopneumoniae antigen und dessen verwendung
DE3884241T2 (de) Analoge des Porcin-Wachstumshormones.
DE69128095T2 (de) Azelluläre impfstoffe
Willatts Addition to the Catalogue of Early Iron Graveslabs in the Weald1